Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.37 |
| ▸ | RORC | P51449 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | SCN1A | P35498 | 1/20 | 0.35 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.35 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.35 |
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1709674 | 0.94 | GHSR (0.61) | GHSRALDH1A1L3MBTL1OPRK1OPRM1 | |
| SCHEMBL1709547 | 0.93 | GHSR (0.75) | GHSRALDH1A1GAAOPRK1OPRM1 | |
| SCHEMBL10122103 | 0.92 | GHSR (0.65) | GHSRALDH1A1L3MBTL1GAAOPRM1 | |
| SCHEMBL1709683 | 0.91 | GHSR (0.59) | GHSRALDH1A1L3MBTL1GAAOPRK1 | |
| SCHEMBL10121682 | 0.91 | GHSR (0.69) | GHSRL3MBTL1GAAOPRM1SCN1A | |
| SCHEMBL10121950 | 0.91 | GHSR (0.64) | GHSRALDH1A1GAARORCPOLB | |
| SCHEMBL10121676 | 0.91 | GHSR (0.64) | GHSRALDH1A1L3MBTL1GAAOPRK1 | |
| SCHEMBL10121683 | 0.90 | GHSR (0.63) | GHSRALDH1A1GAAOPRM1POLB | |
| SCHEMBL1709551 | 0.90 | GHSR (0.63) | GHSRL3MBTL1GAAOPRM1CA12 | |
| SCHEMBL1709677 | 0.90 | GHSR (0.63) | GHSRL3MBTL1GAARORCSCN1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120088747-A1 | SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF | ELIXIR PHARMACEUTICALS, INC. | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088747-A1 | SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF | GHSR, GHRHR, STS | GHSR 1/4885ALDH1A1 3182/4885L3MBTL1 4633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.